<VariationArchive VariationID="1509542" VariationName="NC_000012.11:g.(?_121172765)_(121176235_?)del" VariationType="Deletion" Accession="VCV001509542" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1365163" VariationID="1509542">
      <GeneList>
        <Gene Symbol="ACADS" FullName="acyl-CoA dehydrogenase short chain" GeneID="35" HGNC_ID="HGNC:90" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="120725826" stop="120740008" display_start="120725826" display_stop="120740008" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="121163570" stop="121177810" display_start="121163570" display_stop="121177810" Strand="+" />
          </Location>
          <OMIM>606885</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000012.11:g.(?_121172765)_(121176235_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q24.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" innerStart="121172765" innerStop="121176235" display_start="121172765" display_stop="121176235" variantLength="3471" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.(?_121172765)_(121176235_?)del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.(?_121172765)_(121176235_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000012.11:g.(?_121172765)_(121176235_?)del AND Deficiency of butyryl-CoA dehydrogenase" Accession="RCV002017982" Version="5">
        <ClassifiedConditionList TraitSetID="1053">
          <ClassifiedCondition DB="MedGen" ID="C0342783">Deficiency of butyryl-CoA dehydrogenase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12736383</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14506246</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18523805</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9499414</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-11">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1053" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="82" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lipid-storage myopathy secondary to short chain acyl CoA dehydrogenase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of butyryl-CoA dehydrogenase</ElementValue>
                <XRef ID="Short+chain+acyl+CoA+dehydrogenase+deficiency/6545" DB="Genetic Alliance" />
                <XRef ID="124166007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCAD DEFICIENCY, MILD</ElementValue>
                <XRef Type="Allelic variant" ID="606885.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606885.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606885.0014" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF</ElementValue>
                <XRef Type="MIM" ID="201470" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACADSD</ElementValue>
                <XRef Type="MIM" ID="201470" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SCAD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Most infants with short-chain acyl-CoA dehydrogenase deficiency (SCADD) identified through newborn screening programs have remained well, and asymptomatic relatives who meet diagnostic criteria are reported. Thus, SCADD is now viewed as a biochemical phenotype rather than a disease. A broad range of clinical findings was originally reported in those with confirmed SCADD, including severe dysmorphic facial features, feeding difficulties / failure to thrive, metabolic acidosis, ketotic hypoglycemia, lethargy, developmental delay, seizures, hypotonia, dystonia, and myopathy. However, individuals with no symptoms were also reported. In a large series of affected individuals detected on metabolic evaluation for developmental delay, 20% had failure to thrive, feeding difficulties, and hypotonia; 22% had seizures; and 30% had hypotonia without seizures. In contrast, the majority of infants with SCADD have been detected by expanded newborn screening, and the great majority of these infants remain asymptomatic. As with other fatty acid oxidation deficiencies, characteristic biochemical findings of SCADD may be absent except during times of physiologic stress such as fasting and illness. A diagnosis of SCADD based on clinical findings should not preclude additional testing to look for other causes.</Attribute>
                <XRef ID="NBK63582" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism">May be benign</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4822" />
                <XRef ID="4822" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21938826</ID>
                <ID Source="BookShelf">NBK63582</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C4.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C4 Acylcarnitine, Short-Chain Acyl-CoA Dehydrogenase (SCAD) Deficiency, 2022</CitationText>
              </Citation>
              <XRef ID="26792" DB="Orphanet" />
              <XRef ID="C0342783" DB="MedGen" />
              <XRef ID="MONDO:0008722" DB="MONDO" />
              <XRef Type="MIM" ID="201470" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4319554" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_000017.3_12_Partial deletion (exons 3-6)_121172764_121176235|MedGen:C0342783" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002300567" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9499414</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14506246</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12736383</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18523805</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ACADS protein in which other variant(s) (p.Gly92Cys) have been determined to be pathogenic (PMID: 9499414, 14506246). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with ACADS-related conditions. This variant results in the deletion of exons 3-5 and part of exon 6 of the ACADS gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ACADS are known to be pathogenic (PMID: 12736383, 18523805).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.(?_121172765)_(121176235_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342783" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4319554" TraitType="Disease" MappingType="XRef" MappingValue="C0342783" MappingRef="MedGen">
        <MedGen CUI="C0342783" Name="Deficiency of butyryl-CoA dehydrogenase" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

